Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling.

Li L, Lei QS, Zhang SJ, Kong LN, Qin B.

PLoS One. 2016 May 26;11(5):e0156496. doi: 10.1371/journal.pone.0156496. eCollection 2016. Erratum in: PLoS One. 2016;11(7):e0159019.

2.

Differential roles of hypoxia and innate immunity in juvenile and adult dermatomyositis.

Preuße C, Allenbach Y, Hoffmann O, Goebel HH, Pehl D, Radke J, Doeser A, Schneider U, Alten RH, Kallinich T, Benveniste O, von Moers A, Schoser B, Schara U, Stenzel W.

Acta Neuropathol Commun. 2016 Apr 27;4(1):45. doi: 10.1186/s40478-016-0308-5.

3.

Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials.

Alexopoulos H, Biba A, Dalakas MC.

Neurotherapeutics. 2016 Jan;13(1):20-33. doi: 10.1007/s13311-015-0402-6.

PMID:
26566961
4.

Scanning for Therapeutic Targets within the Cytokine Network of Idiopathic Inflammatory Myopathies.

De Paepe B, Zschüntzsch J.

Int J Mol Sci. 2015 Aug 11;16(8):18683-713. doi: 10.3390/ijms160818683. Review.

5.

Does antigen masking by ubiquitin chains protect from the development of autoimmune diseases?

Weil R.

Front Immunol. 2014 Jun 3;5:262. doi: 10.3389/fimmu.2014.00262. eCollection 2014. Review.

6.
7.

Suppression of soluble T cell-associated proteins by an anti-interferon-α monoclonal antibody in adult patients with dermatomyositis or polymyositis.

Guo X, Higgs BW, Rebelatto M, Zhu W, Greth W, Yao Y, Roskos LK, White WI.

Rheumatology (Oxford). 2014 Apr;53(4):686-95. doi: 10.1093/rheumatology/ket413. Epub 2013 Dec 19.

8.

Myeloid related protein induces muscle derived inflammatory mediators in juvenile dermatomyositis.

Nistala K, Varsani H, Wittkowski H, Vogl T, Krol P, Shah V, Mamchaoui K, Brogan PA, Roth J, Wedderburn LR.

Arthritis Res Ther. 2013 Sep 23;15(5):R131. doi: 10.1186/ar4311.

9.

Activation of the ubiquitin proteasome pathway in a mouse model of inflammatory myopathy: a potential therapeutic target.

Rayavarapu S, Coley W, Van der Meulen JH, Cakir E, Tappeta K, Kinder TB, Dillingham BC, Brown KJ, Hathout Y, Nagaraju K.

Arthritis Rheum. 2013 Dec;65(12):3248-58. doi: 10.1002/art.38180.

10.

Type 1 interferons inhibit myotube formation independently of upregulation of interferon-stimulated gene 15.

Franzi S, Salajegheh M, Nazareno R, Greenberg SA.

PLoS One. 2013 Jun 4;8(6):e65362. doi: 10.1371/journal.pone.0065362. Print 2013.

11.

Differential Expression of Wnt Pathway Genes in Sporadic Hepatocellular Carcinomas Infected With Hepatitis B Virus Identified With OligoGE Arrays.

Lin X, Wang Q, Cao Z, Geng M, Cao Y, Liu X.

Hepat Mon. 2013 Jan;13(1):e6192. doi: 10.5812/hepatmon.6192. Epub 2013 Jan 23.

12.

Genomic signatures characterize leukocyte infiltration in myositis muscles.

Zhu W, Streicher K, Shen N, Higgs BW, Morehouse C, Greenlees L, Amato AA, Ranade K, Richman L, Fiorentino D, Jallal B, Greenberg SA, Yao Y.

BMC Med Genomics. 2012 Nov 21;5:53. doi: 10.1186/1755-8794-5-53.

13.

Cardiomyocyte-specific IκB kinase (IKK)/NF-κB activation induces reversible inflammatory cardiomyopathy and heart failure.

Maier HJ, Schips TG, Wietelmann A, Krüger M, Brunner C, Sauter M, Klingel K, Böttger T, Braun T, Wirth T.

Proc Natl Acad Sci U S A. 2012 Jul 17;109(29):11794-9. doi: 10.1073/pnas.1116584109. Epub 2012 Jul 2.

14.

Role of non-immune mechanisms of muscle damage in idiopathic inflammatory myopathies.

Coley W, Rayavarapu S, Nagaraju K.

Arthritis Res Ther. 2012 Apr 27;14(2):209. doi: 10.1186/ar3791. Review.

15.

Type I interferon pathway in adult and juvenile dermatomyositis.

Baechler EC, Bilgic H, Reed AM.

Arthritis Res Ther. 2011;13(6):249. doi: 10.1186/ar3531. Epub 2011 Dec 22. Review.

16.

Autoantibodies against a 43 KDa muscle protein in inclusion body myositis.

Salajegheh M, Lam T, Greenberg SA.

PLoS One. 2011;6(5):e20266. doi: 10.1371/journal.pone.0020266. Epub 2011 May 23.

17.

Dermatomyositis and type 1 interferons.

Greenberg SA.

Curr Rheumatol Rep. 2010 Jun;12(3):198-203. doi: 10.1007/s11926-010-0101-6. Review.

18.

Type 1 interferons and myositis.

Greenberg SA.

Arthritis Res Ther. 2010;12 Suppl 1:S4. doi: 10.1186/ar2885. Epub 2010 Apr 14. Review.

19.

Human plasmacytoid dendritic cell accumulation amplifies their type 1 interferon production.

Liao AP, Salajegheh M, Morehouse C, Nazareno R, Jubin RG, Jallal B, Yao Y, Greenberg SA.

Clin Immunol. 2010 Jul;136(1):130-8. doi: 10.1016/j.clim.2010.02.014. Epub 2010 Mar 25.

Items per page

Supplemental Content

Write to the Help Desk